Sugi Predict

Sugi Predict / Compounds / SCHEMBL15701015

SCHEMBL15701015

SCHEMBL15701015

O=C(Nc1ccc([N+](=O)[O-])cn1)c1cscn1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.58
▸ CYP1A2 P05177 2/20 0.58
▸ NPC1 O15118 9/20 0.58
▸ RAB9A P51151 8/20 0.58
▸ MAPT P10636 10/20 0.55
▸ SMN1; SMN2 Q16637 6/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.54
▸ HTT P42858 1/20 0.51
▸ KMT2A Q03164 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ MAPK1 P28482 1/20 0.48
▸ CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22232691 0.84 GAA (0.69) GAACYP1A2NPC1RAB9AMAPT
SCHEMBL30485792 0.84 GAA (0.69) GAACYP1A2NPC1RAB9AMAPT
SCHEMBL7075041 0.81 NPC1 (0.57) GAACYP1A2NPC1RAB9AMAPT
SCHEMBL26986662 0.80 NPC1 (0.59) GAACYP1A2NPC1RAB9AMAPT
SCHEMBL30354899 0.78 SMN1; SMN2 (0.57) GAACYP1A2NPC1RAB9AMAPT
SCHEMBL29151282 0.78 SMN1; SMN2 (0.57) GAACYP1A2NPC1RAB9AMAPT
SCHEMBL15707368 0.78 MAP3K5 (0.48) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL15701007 0.78 PTGS1 (0.51) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL470927 0.78 RAB9A (0.58) GAACYP1A2NPC1RAB9AMAPT
SCHEMBL22232687 0.77 NPC1 (0.80) GAACYP1A2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4169916-A1 CARBONOHYDRAZONOYL DICYANIDE COMPOUND INCLUDING AT LEAST TWO TYPES OF ARYL OR HETEROARYL LINKED BY NOVEL LINKER, AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP disclosed
CN-115955968-A Carbohydrazone acyldinitrile compounds comprising at least two aryl or heteroaryl groups connected by a novel linker and uses thereof 韩国科学技术研究院 2023-04-11 — — CN disclosed
EP-2914592-B1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INT (DE) 2017-10-11 — — EP disclosed
US-9334249-B2 Inhibitors of cytomegalovirus BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-05-10 — — US disclosed
US-9334249-B2 Inhibitors of cytomegalovirus BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-05-10 — — US disclosed
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-08 — — US disclosed
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-08 — — US disclosed
WO-2014070979-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS CDKN1A, CCNA1, IFNAR1 GAA 978/4885CYP1A2 2131/4885NPC1 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.